MitraClip in Patients With Severe Mitral Regurgitation and Severe Left Ventricular Systolic Dysfunction
Journal
Circulation journal : official journal of the Japanese Circulation Society
Journal Volume
82
Journal Issue
11
Pages
2929
Date Issued
2018-10-25
Author(s)
Abstract
therefore need more evidence to negotiate with policy makers and general practitioners.Unlike in the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) trial, the lower limit of LVEF is 15% in the MITRA-FR study. 8The results of both trials will be announced soon in the near future.Until then, we may be able to elucidate the clinical impact of MitraClip in this group of patients.
SDGs
Publisher
JAPANESE CIRCULATION SOC
Type
journal article